Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12 by Wu, Yunji et al.
	   1	  
Supplemental Information  
for 
Structural basis for enhanced neutralization of HIV-1 by a dimeric IgG 
form of the glycan-recognizing antibody 2G12  
 
Yunji Wu1, Anthony P. West, Jr.1, Helen J. Kim2, Matthew E. Thornton1,3,  
Andrew B. Ward2, Pamela J. Bjorkman1,4, * 
 
1Division of Biology and Biological Engineering 114-96, California Institute of 
Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA 
 
2Department of Integrative Structural and Computational Biology, The Scripps Research 
Institute, La Jolla, CA 92037, USA 
 
3Present address: University of Southern California Keck School of Medicine, Division of 
Maternal Fetal Medicine at the Saban Research Institute of Childrenʼs Hospital of Los 
Angeles, Los Angeles, CA 90027, USA 
 
4Howard Hughes Medical Institute, California Institute of Technology, 1200 East 
California Boulevard, Pasadena, CA 91125, USA 
 
*Correspondence should be addressed to: bjorkman@caltech.edu  
 
Supplemental Results 
Supplemental Experimental Procedures 
Supplemental Table 1 
Supplemental Figures 1-6 
Supplemental References 
	   2	  
Supplemental Results 
 
Calculation of interchain distances for connectivity model for 2G12 dimer/2G12.1 peptide 
complex 
Nineteen residues within the 2G12 hinge region were missing from the (Fab)2 (pdb ID 1OP3) 
and Fc (pdb ID 1H3X) structures used as search models for molecular replacement. Distances 
from the N-termini of the four Fc polypeptide chains to the C-termini of the four (Fab)2 heavy 
chains were measured using coordinates for high resolution models placed into the 2G12 
dimer/2G12.1 structure for residues Pro-238 (N-terminus of Fc) and Lys-228 (C-terminus of the 
(Fab)2 heavy chain) (residue numbering based on the structures of 2G12 (Fab)2 (pdb ID 1OP3) 
and Fc (pdb ID 1H3X)).  
 
Solution studies of 2G12 monomer and 2G12 dimer  
Small-angle X-ray scattering (SAXS) can be used to derive ab initio information about the size, 
shape and flexibility of proteins in solution (Putnam et al., 2007). To obtain independent 
structural information for 2G12 dimer, we used SAXS to investigate the conformational range of 
2G12 dimer (Figure S5). We obtained X-ray scattering profiles (Figure S5E) from solutions of 
purified 2G12 monomer, 2G12 dimer, and Rituximab, a conventional monomeric human IgG 
(Anderson et al., 1997). For each protein, we generated 10 ab initio models (Figure S5A-C) 
using DAMMIF (Franke, 2009), which were superposed, averaged, and filtered using 
DAMAVER (Volkov, 2003). Models filled with dummy atoms showed 2G12 monomer as a 
relatively rigid “slab” with potential flexibility only at the hinge region between the (Fab)2 unit and 
the Fc (Figure S5A). In contrast, models of 2G12 dimer showed a larger molecule with 
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increased conformational flexibility (Figure S5B). Rituximab models showed a thinner but 
conformationally similar molecule to 2G12 dimer (Figure S5C).  
The distance distribution function P(r) was derived through an indirect Fourier transform 
of the scattering curve using GNOM (Svergun, 1992). P(r) was monomodal for 2G12 monomer 
and 2G12 dimer (Figure S5D), corresponding to the profile for a globular protein. P(r) for 
Rituximab exhibited a smaller second peak, suggesting the presence of more elongated 
domains in solution (Figure S5D) (Putnam et al., 2007). P(r) functions for all three proteins 
converged smoothly to zero at Dmax, which corresponded to the maximum linear dimension of 
the scattering particles: 162 Å for 2G12 monomer, 178 Å for Rituximab, and 193 Å for 2G12 
dimer. The differences in apparent size in solution corroborated our findings from the crystal 
structures of 2G12 dimer – as predicted, the gyration space that 2G12 dimer occupied in 
solution was larger than that of both 2G12 monomer and Rituximab. 2G12 monomer, which 
should exhibit limited mobility due to the (Fab)2 domain exchange, indeed had a lower Rg than 
both conventional IgG and 2G12 dimer (Guinier analysis yielded Rg values of 46 ± 0.42 Å, 52 ± 
2.3 Å, and 59 ± 0.67 Å, for 2G12 monomer, Rituximab, and 2G12 dimer, respectively, see 
Figure S5D). Rituximab also exhibited a broader Rg distribution in Guinier analysis than both 
2G12 monomer and dimer, suggesting that the conventional IgG was more flexible in solution 
than 2G12 dimer. 2G12 dimer was in turn more flexible than 2G12 monomer, which exhibited 
the narrowest Rg distribution. The reference model chosen by DAMAVER produced a .fir file in 
DAMMIF, which was used to calculate a back-transform of the final averaged models (Figure 
S5E). Simulated scattering from the averaged models fit the experimental scattering data well, 
with χ2 of fit values between Iexp and Isim of 1.347, 1.202, and 1.218 for 2G12 monomer, 2G12 
dimer, and control IgG Rituximab, respectively (Figure S5E).  
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Supplemental Experimental Procedures 
 
Protein expression and purification 
Purified monomeric HIV-1 gp120 was a gift from Leo Stamatatos and Zachary Caldwell (Seattle 
BioMed) (Sharma et al., 2006). Purified 2G12 (Fab)2 was a gift from Zara Fulton and was 
imaged by Reza Khayat (The Scripps Research Institute). Other reagents, such as control 
monomeric IgGs and purified soluble rat FcRn (which binds human IgG equally as well as rat 
IgG (Huber, 1994)) were provided by members of the Bjorkman laboratory including Paola 
Marcovecchio, Han Gao, Maria Politzer, and Kathryn Huey Tubman. Protein concentrations 
were determined spectrophotometrically using extinction coefficients at 280 nm of 200480 M-1 
cm-1 (2G12 monomer), 400960 M-1 cm-1 (2G12 dimer), 202000 M-1 cm-1  (conventional 
monomeric IgG antibodies), 84900 M-1 cm-1 (rat FcRn), and 146090 M-1 cm-1 (SF162 gp120). 
Extinction coefficients were calculated based on amino acid compositions using ProtParam 
(Artimo et al., 2012). 
 
Crystallization and data collection 
Crystals of 2G12 dimer (space group P6122) were grown in hanging drops by mixing equal 
volumes of 2G12 dimer (11.5 mg/ml) with a solution containing 1.2 M ammonium sulfate, and 
100 mM HEPES pH 7.0 at 20º C. Crystals were cryopreserved in well solution containing 25-
30% glycerol. Data were collected to 7.5 Å resolution at beamline 8.3.1 of the Advanced Light 
Source (ALS) at Lawrence Berkeley National Laboratory (LBNL), and at beamline 12-2 of the 
Stanford Synchrotron Radiation Lightsource (SSRL) at the SLAC National Accelerator 
Laboratory. Over 500 crystals were screened, but all diffracted poorly and were fragile to 
handle. Experiments to improve the quality of the crystals included seeding, glutaraldehyde 
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crosslinking, recrystallization, additives, exchanging into lithium sulfate, exploring 
cryoprotectants, and varying drop composition. Tantalum bromide clusters (Jena Biosciences) 
were soaked into the native crystals, resulting in bright green crystals. SAD data with reflections 
to 10 Å were collected at beamline 8.3.1 of the ALS at LBNL at a single wavelength of 1.255 Å.  
For crystallization of the 2G12 dimer/2G12.1 complex, 2G12.1 peptide (The Polypeptide 
Group) was mixed with 2G12 dimer (11.5 mg/ml) at a 19:1 molar ratio in 24-well hanging drops 
of protein and reservoir solution in equal amounts. Clustered hexagonal crystals formed from 
spherolites by vapor diffusion in 5% Tascimate, 10% PEGMME 5000, and 100 mM HEPES at 
pH 7.0. Crystals were cryopreserved in the well solution containing 30% PEGMME 5000 and 
screened at beamline BL12-2 at the SSRL at SLAC, and the 5 µm microbeam at beamline 23ID-
D at the General Medical Sciences and Cancer Institutes Structural Biology Facility (GM/CAT) at 
the Advanced Photon Source (APS). Upon handling, the clustered crystals occasionally 
disintegrated into smaller, more singular pieces, which were also cryoprotected and screened. 
We also collected usable data sets from large crystals (0.3 mm diameter) that contained 
singular patches.  
 
Model validation calculations 
Calculations using derivative crystals were performed using software in the CCP4 Software 
Suite (Winn et al., 2011) via the ccp4i graphical user interface (Potterton et al., 2003): cad (Winn 
et al., 2011), scaleit (Winn et al., 2011), fft (Read, 1988), followed by Phenix.autosol (Adams et 
al., 2010), and Phenix.emma (Adams et al., 2010). 
 
Small angle X-ray scattering (SAXS) 
Samples for SAXS were concentrated to 17 mg/ml (2G12 monomer), 13 mg/ml (2G12 dimer), 
and 21 mg/ml (Rituximab) and filtered through 0.22 µm membranes. Dialysis to buffer exchange 
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each protein into Phosphate Buffered Saline was performed overnight, and samples were 
diluted for a concentration series of 0.25 mg/ml, 0.5 mg/ml, 0.75 mg/ml, 1.0 mg/ml, 2.5 mg/ml, 
5.0 mg/ml, and 7.5 mg/ml, along with 1-3% glycerol to minimize aggregation caused by radiation 
damage. Data were collected at SSRL beamline 4-2 using a Rayonix MX225-HE detector at a 
distance of 2500 mm, using 1.13 Å wavelength X-rays. For each concentration of each sample, 
15 exposures of 1 second were collected, covering a momentum transfer (q) range of 0.0047–
0.375 1/Å. The scattering profile for the buffer was obtained in the same manner and subtracted 
from the protein profiles. The detector images were integrated, background subtracted, and 
screened for radiation damage using SasTool (Smolsky, 2007). Extrapolation to infinite dilution 
was done with PRIMUS (Konarev, 2003). Guinier analysis was performed using AutoRG, 
distance distribution functions determined with GNOM (Svergun, 1992), and ab initio 
reconstructions were performed using DAMMIF (Franke, 2009) and DAMAVER (Volkov, 2003) 
in the ATSAS package (Petoukhov et al., 2012).  
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Supplemental Table  
Table S1. Data Collection and Refinement Statistics 
 
 
2G12 dimer 
2G12 dimer with 
(Ta6Br12)2+ 
2G12/2G12.1 
peptide 
Data Collection 
 
   
Resolution (Å) 39.8-8.0 (8.3-8.0) 35.0-10.0 (10.34-10.0) 64.9-6.5 (6.7-6.5) 
Space group P612 2 P612 2 P6 
Unit cell a = b = 246 Å  
c = 657 Å 
a = b = 250 Å  
c = 652 Å 
a = b = 375 Å  
c = 64 Å 
α = β = 90°  
γ = 120° 
α = β = 90°  
γ  = 120° 
α = β = 90°  
γ = 120° 
Total reflections 26016 (2520) 90570 113124 (11045) 
Unique reflections 12654 (1260) 11087 (483) 10665 (1022) 
Completeness (%) 96.95 (71.03) 99.0 (89.6) 99.96 (100.00) 
Mean I/σ(I) 6.51 (1.72) 7.6 (1.3) 7.84 (1.51) 
Rmerge 0.088 (0.46) 0.33 (0.78) 0.28 (2.1) 
CC½   0.99 (0.80)  1.0 (0.83) 
CC* 1.0 (0.94)  1.0 (0.95) 
Ranom  0.22 (0.87)  
Anomalous completeness  74.6 (74.4)  
Anomalous multipicity  4.6 (4.7)  
f'  -26.4  
f"  17.0  
    
Refinement 
 
   
Rwork 0.35 (0.35)  0.38 (0.44) 
Rfree 0.37 (0.36)  0.36 (0.39) 
Number of atoms 29250  28984 
Protein residues 3795  3750 
RMS bonds (Å) 0.018  0.037 
RMS angles (°) 1.62  1.78 
Average B-factor (Å2) 159.0  481.0 
*Statistics for the highest-resolution shell are shown in parentheses. 
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Supplemental Figure Legends 
 
Figure S1. Proposed connectivities of 2G12 dimer and 2G12 trimer, related to Figure 1 
 (A,B) Schematic diagrams illustrating how intermolecular domain swapping could lead to 2G12 
dimer (A) and 2G12 trimer (B). The connectivity model allows for the formation of higher order 
multimers, including tetramers (panel C). (C) Size exclusion chromatography profile for 2G12 
proteins after elution from an FcRn affinity column. Peaks labeled as monomer and dimer were 
identified using in-line static light scattering to determine their molecular masses (West et al., 
2009). Peaks migrating at higher apparent molecular weights are labeled as trimer and tetramer. 
 
Figure S2. Heavy atom validation of molecular replacement phases, related to Figure 2 
Data were collected from crystals of 2G12 dimer soaked with tantalum bromide clusters to 10 Å 
resolution at a wavelength of 1.255 Å, chosen to maximize the anomalous diffraction signal of 
tantalum. Using phases derived from the molecular replacement model, we calculated both 
anomalous and isomorphous difference Fourier maps, which each yielded a set of peaks, seven 
of which were common to both maps. We checked the top five potential heavy atom sites by 
iteratively omitting one site, calculating phases with the remaining sites, and then examining 
difference Fourier maps to see if the omitted site was found. Two of the five potential sites, 
iteratively omitted in this way, were independently reproduced. In each calculation of an 
isomorphous difference Fourier map during cross-phasing, three additional sites were 
consistently and independently produced. One site was reproduced in the calculations of 
anomalous difference Fourier maps during cross-phasing. We concluded that the three sites 
that survived the cross-phasing process after appearing consistently in both isomorphous and 
anomalous difference Fourier maps corresponded to tantalum bromide clusters. The putative 
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tantalum bromide sites corresponded to locations on the surface of the 2G12 dimer model. (A) 
Heavy atom sites (colored spheres) on dimer B/C from Figure 2. (B) Heavy atom sites on dimer 
A from Figure 2.  
 
Figure S3. Packing of 2G12/2G12.1 peptide crystals, related to Figure 3 
Half of a unit cell containing three copies of the asymmetric unit in space group P6 is shown. 
The asymmetric unit contains one intact 2G12 dimer (two (Fab)2 units and two Fcs; yellow Cα 
trace) and half of a second 2G12 dimer (one (Fab)2 unit and one Fc; magenta Cα trace). 
Rotation around a crystallographic two-fold axis creates the second half of the magenta dimer, 
which is conformationally the same as the yellow dimer. (A) Green circles show locations of 
antigen binding sites, which do not contact each other in the P6 crystals. Addition of 2G12.1 
peptide to 2G12 dimer disrupted the crystal contacts at the antigen binding sites in the P6122 
2G12 dimer crystals (Figure 2A). (B) Blue circles highlight crystal contacts between Fc regions. 
Similar crystal contacts were found in the P6122 2G12 dimer crystals (Figures 2C, 3C). (C) 
2G12/2G12.1 structure shown as a volume representation (Figure 4C) superimposed on the 
locations of the yellow dimers (left) and magenta dimers (right). 
 
Figure S4. Distinct 2G12 dimer structures, related to Figure 4 
Dimer structures are shown as 25 Å electron density envelopes calculated from (Fab)2 and Fc 
coordinates located by molecular replacement calculations. Side indicates dimers shown with 
side views of (Fab)2 units, top indicates a view in which Fc regions point into the page, and 
bottom indicates a view in which Fc regions point out of the page. (A) Dimer A from Figure 2 
(cyan) (Figure 4A). (B) Dimers B and C from Figure 2 (magenta and indigo) (Figure 4B). (C) 
Dimer from 2G12/2G12.1 peptide structure (Figure 4C). 
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The symmetry of two of the 2G12 dimer conformations, dimer A and the dimer in the 
2G12/2G12.1 peptide structure (panels A and C), was point group C2 (the dimer two-fold 
symmetry axis was coincident with a crystallographic two-fold axis). The dimer B/C 
conformation (panel B) represented a distortion from C2 symmetry. A 2G12 dimer could also 
have point group D2 symmetry with the (Fab)2 units in a similar position as in a C2 dimer except 
with their internal two-fold axes coincident, and with the Fcs above and below the plane of the 
(Fab)2 units with the Fc two-fold axes coincident with each other and perpendicular to the (Fab)2 
two-fold axes. Although the D2 conformation appeared plausible, it was not observed in our 
structures. To interconvert these forms would require one (Fab)2 unit to rotate 180˚. 
 
Figure S5. SAXS Data for 2G12 monomer, dimer, and a conventional IgG monomer, 
related to Figure 5 
Ab initio models filled with dummy atoms revealing size and shape of (A) 2G12 monomer, (B) 
2G12 dimer, and (C) Rituximab, a conventional IgG monomer. (D) Pair-distribution functions and 
Guinier plots from 2G12 monomer, dimer, and Rituximab. Guinier plots calculated from low q 
ranges behaved linearly, indicating minimal aggregation (Hammel, 2012; Mertens and Svergun, 
2010). Differences in Dmax calculated from P(r) were consistent with 2G12 monomerʼs 
comparatively smaller range of motion and Rituximabʼs more freely mobile domains compared 
to 2G12 dimer. (E) Data analyses. Left: Scattering profiles of 2G12 monomer, 2G12 dimer, and 
Rituximab, plotted as log(I) vs. q. Profiles from all concentrations of each protein were 
superimposable when scaled by concentration, indicating low inter-particle forces, properly 
folded species, and ideal sample quality. Accordingly, one representative scattering profile was 
chosen from the concentration series for each individual protein, and merging of multiple 
scattering profiles was not required. Second from left: Traditional Kratky analysis used for 
detecting conformational flexibility via visual inspection (Putnam et al., 2007). Bimodal profiles 
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for 2G12 dimer and Rituximab revealed behavior similar to that of a heterogeneous mixture of 
species. 2G12 dimer exhibited a slowly increasing curve at large q values, suggesting an 
elongated species when compared to Rituximab and 2G12 monomer. Third from left: Analysis of 
samples using Porod-Debye law revealed a loss of plateau in Rituximab when compared with 
2G12 monomer, indicating increased flexibility. 2G12 dimer exhibited a divergent curve at large 
q values, characteristic of an elongated species (Hammel, 2012). Right: Simulated scattering 
from DAMAVER averaged models (red, green, or blue) fit to the experimental scattering data 
(gray), plotted as log(I) vs. q. 
 
Figure S6. SPR sensorgrams containing residuals of 1:1 binding model fits, related to 
Figure 6 
Sensorgrams were derived from binding experiments in which 2G12 monomer, 2G12 dimer, or 
a conventional monomeric anti-gp120 IgG was injected over immobilized gp120 from HIV-1 
strain SF162. Experimental data (colored lines) were fit to a 1:1 binding model (black lines). 
Residual plots are shown in Figure S6. (A) 2G12 monomer, 2G12 dimer, and a conventional 
anti-gp120 IgG (NIH45-46G54W) injected over gp120 immobilized at high coupling density (~100 
RU). 2G12 monomer, but not 2G12 dimer or the conventional IgG, could be fit to a 1:1 binding 
model. (B) 2G12 monomer, 2G12 dimer, and a conventional anti-gp120 IgG (NIH45-46G54W) 
injected over gp120 immobilized at medium coupling density (~50 RU). 2G12 monomer, but not 
2G12 dimer or the conventional IgG, could be fit to a 1:1 binding model. (C) 2G12 monomer, 
2G12 dimer, and a conventional anti-gp120 IgG (2909) injected over gp120 immobilized at low 
coupling density (<10 RU). All could be fit to a 1:1 binding model.  
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